Schedule 13G ownership disclosure

SOL-GEL TECHNOLOGIES LTD

Ordinary Shares, par value NIS 1.00 per share · CUSIP: M8694L137

Event date: 2026-10-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Trails Edge Capital Partners, LP

    Shares: 166,473.00 · Class: 5.1%

  • Trails Edge Biotechnology Master Fund, LP

    Shares: 166,473.00 · Class: 5.1%

  • Ortav Yehudai

    Shares: 166,473.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-048694
Form type
SCHEDULE 13G
Filer
Trails Edge Capital Partners, LP
CIK
CIK 2077247
Filed
Oct 27, 2026
Reporting period
Oct 20, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub